Hematopoietic Growth Factors for the Treatment of Inherited Cytopenias

Seminars in Hematology

Volumn 44, Issue 3, 2007, Pages 133-137

  Zeidler, Cornelia ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ANEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CYTOPENIA; DRUG DOSE INCREASE; FANCONI ANEMIA; GENETIC DISORDER; HUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ANEMIA; ANEMIA, DIAMOND-BLACKFAN; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ERYTHROPOIETIN; FANCONI ANEMIA; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEUTROPENIA; STEM CELL FACTOR; THROMBOCYTOPENIA;

EID: 34447105861     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2007.04.003     Document Type: Article

References (46)

1. Carnot P., and Deflandre C. Sur l'activité hemopoietique de serum au cours de la regeneration du sang. C R Acad Sci 143 (1906) 432-435
2. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haematopoietic cells. Nature 339 (1989) 27-30
3. Kostmann R. Infantile genetic agranulocytosis. Acta Pediatr Scand 45 (1956) 1-78
4. Kostmann R. Infantile genetic agranulocytosis: A review with presentation of ten new cases. Acta Pediatr Scand 64 (1975) 362-368
5. Klein C., Grudzien M., Appaswamy G., Germeshausen M., Sandrock I., Schaffer A.A., et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 39 (2007) 86-92
6. Aprikyan A.A., Liles W.C., Boxer L.A., and Dale D.C. Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. J Pediatr Hematol Oncol 24 (2002) 784-786
7. Dale D.C., Person R.E., Bolyard A.A., Aprikyan A.G., Bos C., Bonilla M.A., Boxer L.A., et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96 (2000) 2317-2322
8. Horwitz M., Benson K.F., Person R.E., Aprikyan A.G., and Dale D.C. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoesis. Nat Genet 23 (1999) 433-436
9. Skokowa J., Cario G., Uenalan M., Schambach A., Germeshausen M., Battmer K., et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 12 (2006) 1191-1197
10. Welte K., Zeidler C., and Dale D.C. Severe congenital neutropenia. Semin Hematol 43 (2006) 189-195
11. Dong F., Brynes R.K., Tidow N., Welte K., Lowenberg B., and Touw I.P. Mutations in the gene for the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333 (1995) 487-493
12. Germeshausen M., Ballmaier M., and Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 109 (2007) 93-99
13. Rappeport J., Parkman R., Newburger P., Camitta B.M., and Chusid M.J. Correction of infantile granulocytosis (Kostmann syndrome) by allogeneic bone marrow transplantation. Am J Med 68 (1980) 605-609
14. Souza L., Boone T., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232 (1986) 61-65
15. Bonilla M., Gillio A., Ruggeiro M., Kernan N.A., Brochstein J.A., Abboud M., et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320 (1989) 1574-1580
16. Bonilla M., Dale D., Zeidler C., Last L., Reiter A., Ruggeiro M., et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congential neutropenias. Br J Hematol 88 (1994) 723-730
17. Donadieu J., Leblanc T., Meunier B.B., Barkaoui M., Fenneteau O., Bertrand Y., et al. Analysis of risk factors for myelodysplasia/leukemia and infectious death among patients with congenital neutropenia: Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90 (2005) 45-53
18. Dale D., Bonilla M., Davis M., Nakanishi A.M., Hammond W.P., Kurtzberg J., et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 81 (1993) 2496-2502
19. Zeidler C., Boxer L., Dale D.C., Freedman M.H., Kinsey S., and Welte K. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 109 (2000) 490-495
20. Welte K., Zeidler C., Reiter A., Muller W., Odenwald E., Souza L., et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75 (1990) 1056-1063
21. Zeidler C., Vogel R., Wyres M., and Welte K. Beneficial effects of stem cell factor (SCF) in children with severe congenital neutropenias refractory to G-CSF. Blood 92 (1998) 380a (abstr)
22. Zeidler C., Welte K., Barak Y., Barriga F., Bolyard A.A., Boxer L., et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 95 (2000) 1195-1198
23. Gilman P., Jackson D., and Guild H. Congenital agranulocytosis: Prolonged survival and terminal acute leukemia. Blood 36 (1970) 576-585
24. Rosen R., and Kang S. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 94 (1979) 406-408
25. Rosenberg P.S., Alter B.P., Bolyard A.A., Bonilla M.A., Boxer L.A., Cham B., et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107 (2005) 4628-4635
26. Winearls C.H., Oliver D.O., Pippard M.J., Reid C., Downing M.R., and Cotes P.M. Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis. Lancet 2 (1986) 1175
27. Das R.E.G., Milne A., Rowley M., Smith E.C.G., and Cotes P.M. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anemias. Br J Haematol 82 (1992) 601
28. Hammond D., and Keighley G. The erythrocyte-stimulating factor in serum and urine in congenital hypoplastic anemia. Am J Dis Child 100 (1960) 466
29. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21 (1999) 169-175
30. Gazda H.T., Grabowska A., Merida-Long L.B., Latawiec E., Schneider H.E., Lipton J.M., et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 79 (2006) 1110-1118
31. Niemeyer C.M., Baumgarten E., Holldack J., Meier I., Trenn G., Jobke A., et al. Treatment trial with recombinant human erythropoietin in children with congenital hypoplastic anemia. Contrib Nephrol 88 (1991) 276-280
32. Dunbar C.E., Smith D.A., Kimball J., Garrison J., Nienhues A.W., and Young N.S. Treatment of Diamond-Blasckfan anemia with hematopoiesis growth factors, granulocyte-macrophage colony-stimulating factor and interleukin-3: Sustained remission following IL-3. Br J Haematol 79 (1991) 316-321
33. Gillio A.P., Faulkner L.B., Alter B.P., Reilly L., Klafter R., Heller G., et al. Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood 82 (1993) 744-751
34. Olivieri F., Feig S.A., Valentino L., Berriman A.M., Shore R., and Freedman M.H. Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia. Blood 83 (1994) 2444-2450
35. Tamary H., Shalev H., Pinsk V., Zoldan M., and Zaizov R. No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I. Pediatr Hematol Oncol 16 (1999) 165-168
36. Heimpel H., Schwarz K., Ebnöther M., Goede J.S., Heydrich D., Kamp T., et al. Congenital dyserythropoietic anemia type I (CDA I): Molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107 (2006) 334-340
37. Geddis A.E. Inherited thrombocytopenia: Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Semin Hematol 43 (2006) 196-203
38. King S., Germeshausen M., Strauss G., Welte K., and Ballmaier M. Congenital amegakaryocytic thrombocytopenia: A retrospective clinical analysis of 20 patients. Br J Haematol 131 (2005) 636-644
39. Germeshausen M., Ballmaier M., and Welte K. c-mpl mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mut 27 (2006) 296
40. Wang Z., Skokowa J., Pramono A., Ballmaier M., and Welte K. Thrombopoietin regulates differentiation of Rhesus monkey embryonic stem cells to hematopoietic cells. Ann N Y Acad Sci 1044 (2005) 29-40
41. Kutler D.I., Singh B., and Satagopan J. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101 (2003) 1249-1256
42. Guinan E.C., Lopez K.D., Huhn R.D., Felser J.M., and Nathan D.G. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia. J Pediatr 124 (1994) 144-150
43. Rackoff W.R., Orazi A., Robinson C.A., Cooper R.J., Alter B.P., Freedman M.H., et al. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: A pilot study. Blood 88 (1996) 1588-1593
44. Scagni P., Saracco P., Timeus F., Farinasso L., Dall'Aglio M., Bosa E.M., et al. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia. Haematologica 83 (1998) 432-437
45. Croop J.M., Cooper R., Fernandez C., Graves V., Kreissman S., Hanenberg H., et al. Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. Blood 98 (2001) 2917-2921
46. Si Y., Ciccone S., Yang F.C., Yuan J., Zeng D., Chen S., et al. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/-and Fancg-/- mice. Blood 108 (2006) 4283-4287